CT Crescita Therapeutics Inc. Stock: price and insider trades · Canada · SEDISource id SEDI:crescita-therapeutics-inc CA · SEDI Mcap CA$14.7M Track the Crescita Therapeutics Inc. share price and the full directors' dealings record of the company, a publicly traded company based in Canada. Shares are quoted on the CA market, under the oversight of SEDI. Market capitalisation: €14.7m. The latest transaction was disclosed on 9 June 2026 (58 - Expiration of rights). Among the most active insiders: Chicoine, Daniel. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,982 of 29,064 companies
FCF yld 5.0%
Earn yld -0.6%
EV/EBITDA 10.3x
ROE -2.2%
Gross mgn 53%
Net mgn -0.4%
Debt/EBITDA 0.2x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 June 2026
All Executives32 Thresholds0 Prospectus0 Other0
Declarations 32 total
● 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 1 Jan 2025
120,000 shares Share Appreciation Rights Plan (SAR) SEDI:4732286 ● 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 1 Jan 2024
150,000 shares Share Appreciation Rights Plan (SAR) SEDI:4732285 ▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
513,000 shares Share Appreciation Rights Plan (SAR) SEDI:4732284 Canonical exit: 1 Sept 2026 (T+90) ▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
997,771 shares Options SEDI:4732283 Canonical exit: 1 Sept 2026 (T+90) ● 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 1 Jan 2024
45,250 shares Share Appreciation Rights Plan (SAR) SEDI:4732281 ● 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 1 Jan 2025
48,000 shares Share Appreciation Rights Plan (SAR) SEDI:4732280 ▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
228,500 shares Share Appreciation Rights Plan (SAR) SEDI:4732278 Canonical exit: 1 Sept 2026 (T+90) ▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
423,000 shares Options SEDI:4732270 Canonical exit: 1 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
142,500 shares Options SEDI:4732268 Canonical exit: 1 Sept 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 3 Jun 2026
121,508 shares @ CA$0.80 100.0% of flow Deferred Share Units (DSU) SEDI:4732053 Canonical exit: 1 Sept 2026 (T+90) ◇ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 6 May 2024
59,158 shares Options SEDI:4732052 ▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
632,000 shares @ CA$0.80 35.4% of flow Options SEDI:4732051 Canonical exit: 1 Sept 2026 (T+90) ▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
95,273 shares @ CA$0.80 5.3% of flow Deferred Share Units (DSU) SEDI:4732050 Canonical exit: 1 Sept 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 3 Jun 2026
95,273 shares @ CA$0.80 27.4% of flow Deferred Share Units (DSU) SEDI:4732049 Canonical exit: 1 Sept 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 3 Jun 2026
95,273 shares @ CA$0.80 62.0% of flow Deferred Share Units (DSU) SEDI:4732048 Canonical exit: 1 Sept 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 3 Jun 2026
58,500 shares @ CA$0.80 38.0% of flow Options SEDI:4732047 Canonical exit: 1 Sept 2026 (T+90) ◇ 4 - Director of Issuer · Executives · 6 May 2024
59,158 shares Options SEDI:4732046 ▲ 4 - Director of Issuer · Executives · 3 Jun 2026
58,500 shares @ CA$0.80 16.8% of flow Options SEDI:4732045 Canonical exit: 1 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
32,800 shares @ CA$0.80 4.4% of flow Common Shares SEDI:4732044 Canonical exit: 1 Sept 2026 (T+90) ▲ 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
49,600 shares @ CA$0.80 6.7% of flow Common Shares SEDI:4732043 Canonical exit: 1 Sept 2026 (T+90) ▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
124,879 shares @ CA$0.80 7.0% of flow Common Shares SEDI:4732042 Canonical exit: 1 Sept 2026 (T+90) ▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
11,900 shares @ CA$0.80 0.7% of flow Common Shares SEDI:4732041 Canonical exit: 1 Sept 2026 (T+90) ▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
116,227 shares @ CA$0.80 6.5% of flow Common Shares SEDI:4732040 Canonical exit: 1 Sept 2026 (T+90) ▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
38,795 shares @ CA$0.80 2.2% of flow Common Shares SEDI:4732039 Canonical exit: 1 Sept 2026 (T+90) ▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
119,577 shares @ CA$0.80 6.7% of flow Common Shares SEDI:4732038 Canonical exit: 1 Sept 2026 (T+90) 25 of 32 declarations
Load more (7 remaining) 关于 Crescita Therapeutics Inc. Crescita Therapeutics Inc. 是一家专注于开发医药产品和护肤解决方案的公司。该公司在 XTSE 市场上市。